Sign in

CIK 0001006028

  • Non-accelerated filer
  • Smaller reporting company

PURE BIOSCIENCE, INC.

Sign in to watch
Ticker
PURE
Exchange
OTC
Industry
Miscellaneous Chemical Products
FY end
Jul 31
Incorporated
DE
Entity type
Operating
EIN
330530289
Phone
+1 619-596-8600
Business address
771 JAMACHA ROAD #512, EL CAJON, CA, 92019
Former names
PURE BIOSCIENCE, INNOVATIVE MEDICAL SERVICES
  1. 4 Open-market buy Chief Executive Officer bought 78,721 shares at an average $0.66 ($52,248)
  2. 4 Other disposition Chief Executive Officer disposed of 10,732,222 shares (other)
  3. 4 Open-market buy Chief Executive Officer bought 53,124 shares at an average $1.76 ($93,570)
  4. 4 Grant or award Chief Operating Officer acquired 500,000 shares (grant or award)
  5. 4 Open-market buy Chief Executive Officer bought 202,033 shares at an average $1.74 ($351,871)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Director acquired 1,551,724 shares (grant or award)
  12. 4 Grant or award Director acquired 2,243,103 shares (grant or award)
  13. 4 Grant or award Director acquired 179,311 shares (grant or award)
  14. 4 Open-market sale Director sold 788,880 shares at an average $0.29 ($228,375)
  15. 4 Open-market buy Director bought 754,884 shares at $0.29 ($218,161)
  16. 4/A Grant or award Director acquired 862,068 shares (grant or award)
  17. 4/A Grant or award Director acquired 1,000,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 20 · 384 filings